Objectives
depression, fatigue, anxiety, pain
SECONDARY
This study aimed to examine short-term (ie, 3 months) efficacy findings from an RCT testing the digital pain self-management intervention program EPIO. It was hypothesized that participants receiving EPIO, compared with participants in a care-as-usual control group, would experience significant improvements in primary (ie, pain interference) and secondary (ie, depression, anxiety, self-regulatory fatigue, HRQoL, pain catastrophizing, and pain acceptance) outcomes after 3 months of access to the EPIO program. System use, usefulness, and ease of use were examined on an exploratory basis.